Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    Shares to buy now: why I’d consider Lloyds Banking Group alongside this FTSE 100 stock

    | Kevin Godbold

    Since July, this FTSE 100 company's share price has been trending down. But the decline is at odds with the…

    Read more »

    Investing Articles

    AstraZeneca share price: is this FTSE 100 growth stock now a top ‘dip buy’?

    | G A Chester

    The AstraZeneca share price has underperformed the FTSE 100 in recent months. G A Chester weighs up its dip-buy credentials.

    Read more »

    Investing Articles

    The AstraZeneca share price: why I’d buy and hold the stock

    | Rupert Hargreaves

    The AstraZeneca share price has an attractive long-term outlook, thanks to its expansive portfolio of drugs and new treatments.

    Read more »

    Investing Articles

    AstraZeneca: why I’m forgetting the headlines and following the trendlines

    | Tej Kohli

    AstraZeneca is forging ahead with its portfolio of ‘on trend’ medicines that should prove increasingly profitable.

    Read more »

    Investing Articles

    AstraZeneca shares: 4 reasons I’d buy them now

    | Manika Premsingh

    The AZN share price has been subdued for the last few months, but Manika Premsingh thinks that’s about to change. 

    Read more »

    Investing Articles

    FTSE 100 shares to buy: AstraZeneca has rediscovered its growth mojo

    | Kevin Godbold

    Here's why I like the look of AstraZeneca shares today and I think the investment risks are balanced by the…

    Read more »

    Investing Articles

    Top British stocks for February 2021

    | The Motley Fool Staff

    We asked our freelance writers to share their top British stocks for February, including Lloyds Banking Group and Computacenter.

    Read more »

    Investing Articles

    Events I think that could send AstraZeneca shares rallying in 2021

    | Jay Yao

    Given the start of 2021, Jay Yao writes what he thinks are events that could send AstraZeneca shares potentially higher…

    Read more »

    Investing Articles

    My 2 best shares for 2021

    | Karl Loomes

    As the New Year starts, now is the perfect time to look for investments that should do well this year.…

    Read more »

    Investing Articles

    AstraZeneca shares: Hargreaves Lansdown investors are buying. Should I buy too?

    | Roland Head

    AstraZeneca shares have fallen by more than 25% since last summer. Roland Head has been taking a fresh look. Is…

    Read more »

    Investing Articles

    AstraZeneca’s Covid-19 vaccine approved! Here’s what I’d do now

    | Zaven Boyrazian, MSc

    Approval for AstraZeneca’s vaccine brings the UK a step closer to winning the fight against Covid-19. But is there a…

    Read more »

    Investing Articles

    Will the AstraZeneca share price be the largest FTSE 100 riser in 2021?

    | Stuart Blair

    The AstraZeneca share price has performed well under Pascal Soriot. After its acquisition of Alexion, will it rise further in…

    Read more »